Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs
NCT03268317 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2017-08-31
Summary
Neuropsychiatric adverse effects of direct acting antiviral drugs, especially Sofosbuvir and Daclatasvir combination therapy (with or without ribavirin) in patients with chronic hepatitis C , genotype four (the predominant genotype in Egypt).
Conditions
- Hepatitis C
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-31
- Primary Completion
- 2019-01-31
- Completion
- 2020-01-31
More Related Trials
-
Metabolic Changes in Chronic HCV Patients Receiving DAAS
NCT04211844 ·Status: UNKNOWN
-
Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes
NCT02650024 ·Status: COMPLETED
-
Effects of Direct-acting Antiviral Agents on HCV Cognitive Function, and Depression in HCV Related Cirrhosis: A Prospective Clinical Trial
NCT04330508 ·Status: COMPLETED
-
the Possible Effect of the Antiviral Inhibitors for Treatment of Hepatitis C Virus Infection in Cardiac Function
NCT03166943 ·Status: UNKNOWN ·Phase: NA
-
Quality of Life in Patients With HCV Related Liver Cirrhosis Before and After Direct Acting Antiviral Drugs
NCT03897608 ·Status: UNKNOWN
-
Effect of Direct-acting Antiviral Drugs on Erectile Function
NCT03444272 ·Status: UNKNOWN ·Phase: PHASE3
-
Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C
NCT03402165 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related
NCT03313154 ·Status: COMPLETED
-
Treatment of Hepatitis c by Using Direct-acting Antiviral
NCT05372874 ·Status: UNKNOWN
-
HCV Treatment Initiation During Acute Psychiatric Admission
NCT04625322 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Antiviral Therapy With Pegylated Interferon-alpha on Auditory Disability
NCT01265693 ·Status: COMPLETED
-
the Pulmonary Safety of Antihepatitis C Treatment
NCT04122066 ·Status: UNKNOWN
-
Changes in Cognition in HCV Patients After Virus Eradication With Direct Antiviral Agents
NCT03508115 ·Status: COMPLETED
-
Treatment of Hepatitis C in Psychiatric Patients
NCT00751426 ·Status: COMPLETED
-
Neurocognitive Functioning in Patients With Hepatitis C Pre- and Post-Treatment With Antiviral Medication
NCT00188201 ·Status: UNKNOWN
-
Study on the Prevalence of Hepatitis C In a psychiatRic Population
NCT04600479 ·Status: COMPLETED ·Phase: NA
-
Psychobiological Characterization of Depression in Hepatitis C
NCT01492478 ·Status: UNKNOWN
-
The Effect of High Dose Vitamin C on the Liver Function in Chronic Hepatitis Patients
NCT01413360 ·Status: COMPLETED ·Phase: PHASE4
-
Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)
NCT01448915 ·Status: COMPLETED
-
Pharmacist-led Hepatitis C Management
NCT04322981 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of HIV and Hepatitis C Virus on the Brain
NCT00494936 ·Status: COMPLETED
-
Cognitive Impairments in Chronic Hepatitis C Patients and Potential Reversibility With New Agents (CICHepC)
NCT02745132 ·Status: UNKNOWN ·Phase: PHASE4
-
Risk of HCC in Cirrhotic Patients Post DAAs Ttt
NCT03414554 ·Status: UNKNOWN
-
Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy
NCT00747539 ·Status: COMPLETED
-
The Pathogenesis of Hepatitis C Virus Vertical Transmission
NCT01921400 ·Status: COMPLETED